NK cells in pregnant patients with SLE: A preliminary study;Estudo-piloto: Células NK nas gestantes com LES

Revista Brasileira de Reumatologia

Volumn 49, Issue 4, 2009, Pages 387-401

  Pereira, Alessandra Cardoso ^a,b   Dos Santos Lima, Mônica Cristina Brandão ^c   De Jesús, Nilson Ramires ^d   França, Marcus Montello ^e   Da Silva Nahum Jr , Homero ^f   Levy, Roger Abramino ^d  

^a Faculdade de Medicina (UNIGRANRIO)   (Brazil)

^b Ciências Médicas do PGCM ^*

^c Laboratório de Imunopatologia   (Brazil)

^d Disciplina de Reumatologia   (Brazil)

^e HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^f ESTÁCIO DE SÁ UNIVERSITY   (Brazil)

Author keywords

NK cells; Pregnancy; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; HYDROXYCHLOROQUINE; LIPOCORTIN 5; PREDNISONE; PROPIDIUM IODIDE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL COUNT; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PATHOGENESIS; PREGNANCY; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 70449672750     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042009000400006     Document Type: Article

References (26)

1. Baxter AG, Smyth MJ. The Role of NK Cells in Autoimmune Disease. Autoimmunity 2002;35:1-14.
2. Ruddy S, Harris Jr ED, Sledge CB. Kelley's Textbook of Rheumatology, 6. ed, Philadelphia: Saunders, 2001.
3. Sigal LH. Natural Killer Cell Receptors and Activation Mechanisms. J Clin Rheumatol 2003;9:55-59
4. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M et al. Human Cytotrophoblasts Adopt a Vascular Phenotype as They Differentiate. A Strategy for Successful Endovascular Invasion? J Clin Invest 1997;99:2139-2151
5. Sacks G, Sargent I, Redman C. An Innate View of Human Pregnancy. Immunol Today 1999;20:114-118
6. Moffett-King A. Natural Killer and Pregnancy. Nat Rev Immunol 2002;2:656-663
7. Lobo SC, Huang ST, Germeyer A, Dosiou C, Vo KC, Tulac S et al. The Immune Environment in Human Endometrium during the Window of Implantation. Am J Reprod Immunol 2004;52:244-251 (Pubitemid 39462194)
8. Verma S, Hiby SE, LokeYW, King A. Human Decidual Natural Killer Cells Express the Receptor for and Respond to the Cytokine Interleukin 15. Biol Reprod 2000;62:959-968 (Pubitemid 30173809)
9. Manaster I, Mandelboim O. The Unique Properties of Human NK Cells in the Uterine Mucosa. Placenta 2008;29:S60-6.
10. Ruiz-Irastorza G, Khamashta MA. Evaluation of Systemic Lupus Erythematous Activity during Pregnancy. Lupus 2004;13:679-682 (Pubitemid 39279783)
11. Wilder RL. Hormones, Pregnancy, and Autoimmune Diseases. Ann NY Acad Sci 1998;840:45-50.
12. Green MRJ, Kennell ASM, Larche MJ, Seifert MH, Isemberg DA, Salaman MR. Natural Killer Cell Activity in Families of Patients with Systemic Lupus Erythematosus: Demonstration of a Killing Defect in Patients. Clin Exp Immunol 2005;141:165-173
13. Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G et al. Assessing Disease Activity in SLE Patients during Pregnancy. Lupus 1999;8:677-684 (Pubitemid 29520535)
14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A Disease Activity Index for Lupus Patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-640
15. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH et al. The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: a Randomized Trial. Ann Intern Med 2005;142:953-962 (Pubitemid 40840309)
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A Novel Assay for Apoptosis. Flow Cytometric Detection of Phosphatidylserine Expression on Early Apoptotic Cells Using Fluorescein Labelled. Annexin V. J Immunol Meth 1995;184:39-51.
17. Costa Neto, PLO. Estatística, 2 ed. São Paulo: Edgard Blucher, 2002.
18. Bunchaft G, Kellner SRO. Estatística sem mistério. Petrópolis: Vozes, 1999, pp. 350-899.
19. Beiguelman B. Curso prático de bioestatística. 5 ed. Ribeirão Preto: FUNPEC 73-212, 2002.
20. Siegel S, Castellan Jr NJ. Estatística não- paramétrica para ciências do comportamento. 6 ed. Porto Alegre: Artmed 2006, pp. 134-178.
21. Kwak-Kim J, Gilman-Sachs A. Clinical Implication of Natural Killer Cells and Reproduction. Am J Reprod Immunol 2008;59:388-400.
22. Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S. Evolution of Non-Cytotoxic Uterine Natural Killer Cells. Am J Reprod Immunol 2008;59:425-432
23. Petri M. Prospective Study of Systemic Lupus Erythematosus Pregnancies. Lupus 2004;13:688-689 (Pubitemid 39279785)
24. Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, Kärre K et al. Increased Proportion of CD56(bright) Natural Killer Cells in Active and Inactive Systemic Lupus Erythematosus. Immunology 2008 Jun 18 - in press.
25. Clark DA. Immunological Factors in Pregnancy Wastage: Fact or Fiction. Am J Reprod Immunol 2008;59:277-300.
26. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH. Decreased Phagocytosis of Apoptotic Cells in Diseased SLE mice. J Autoimmun 2004;22:139-145 (Pubitemid 38252970)